Investigational Site Number :1580006
Taipei 112
0 studies enrolling now · 1 studies all time
What they study most
Neoplasm
Studies at this site
Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies
— Stopped early